StockData
Ardelyx, Inc. logo

Ardelyx, Inc. (ARDX) stock

ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3059% below fair value
$3.09−0.03 (-0.96%)

Close on Nov 13, 2026Market cap $769.99MP/E –Yield –

Ardelyx total assets

Total assets on the balance sheet at the end of each period.

Ardelyx's total assets was $575.89M at Jun 30, 2026. For fiscal 2025 it was $501.60M, up 15.1% from the year before. Over ten years it grew 15.7% a year on average. The highest annual figure on record is $501.60M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$501.60M+15.1%
FY2024Dec 31, 2024$435.75M+46.4%
FY2023Dec 31, 2023$297.58M+56.6%
FY2022Dec 31, 2022$190.07M+26.8%
FY2021Dec 31, 2021$149.91M-25.6%
FY2020Dec 31, 2020$201.56M-22.4%
FY2019Dec 31, 2019$259.78M+41.7%
FY2018Dec 31, 2018$183.33M+16.1%
FY2017Dec 31, 2017$157.90M-25.9%
FY2016Dec 31, 2016$213.13M+82.2%
FY2015Dec 31, 2015$116.95M+3.1%
FY2014Dec 31, 2014$113.41M+164.3%
FY2013Dec 31, 2013$42.90M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$575.89M+23.4%
Q1 FY2026Mar 31, 2026$504.51M+23.0%
Q4 FY2025Dec 31, 2025$501.60M+15.1%
Q3 FY2025Sep 30, 2025$486.17M+32.2%
Q2 FY2025Jun 30, 2025$466.77M+35.9%
Q1 FY2025Mar 31, 2025$410.19M+19.8%
Q4 FY2024Dec 31, 2024$435.75M+46.4%
Q3 FY2024Sep 30, 2024$367.86M+27.1%
Q2 FY2024Jun 30, 2024$343.49M+62.6%
Q1 FY2024Mar 31, 2024$342.38M+57.8%
Q4 FY2023Dec 31, 2023$297.58M+56.6%
Q3 FY2023Sep 30, 2023$289.38M+100.0%
Q2 FY2023Jun 30, 2023$211.20M+60.5%
Q1 FY2023Mar 31, 2023$217.02M+67.7%
Q4 FY2022Dec 31, 2022$190.07M+26.8%
Q3 FY2022Sep 30, 2022$144.67M-15.3%
Q2 FY2022Jun 30, 2022$131.61M-35.8%
Q1 FY2022Mar 31, 2022$129.41M-38.5%
Q4 FY2021Dec 31, 2021$149.91M-25.6%
Q3 FY2021Sep 30, 2021$170.85M-14.0%
Q2 FY2021Jun 30, 2021$204.98M-5.7%
Q1 FY2021Mar 31, 2021$210.29M-10.6%
Q4 FY2020Dec 31, 2020$201.56M-22.4%
Q3 FY2020Sep 30, 2020$198.56M+66.3%
Q2 FY2020Jun 30, 2020$217.34M+57.5%
Q1 FY2020Mar 31, 2020$235.32M+41.6%
Q4 FY2019Dec 31, 2019$259.78M+41.7%
Q3 FY2019Sep 30, 2019$119.41M-42.2%
Q2 FY2019Jun 30, 2019$137.98M-39.6%
Q1 FY2019Mar 31, 2019$166.14M+16.3%
Q4 FY2018Dec 31, 2018$183.33M+16.1%
Q3 FY2018Sep 30, 2018$206.67M+44.4%
Q2 FY2018Jun 30, 2018$228.54M+39.2%
Q1 FY2018Mar 31, 2018$142.84M-23.9%
Q4 FY2017Dec 31, 2017$157.90M-25.9%
Q3 FY2017Sep 30, 2017$143.11M-40.7%
Q2 FY2017Jun 30, 2017$164.12M–
Q1 FY2017Mar 31, 2017$187.77M–
Q4 FY2016Dec 31, 2016$213.13M–
Q3 FY2016Sep 30, 2016$241.32M–

More Ardelyx figures

See a number that looks wrong?